Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01764789 · ClinicalTrials.gov registry record · NA
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT01764789: Completed NA study, sponsored by Ohio State University Comprehensive Cancer Center.
NCT01764789 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 39 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01764789, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
This pilot clinical trial studies stress reduction in improving quality of life in patients with recurrent gynecologic or breast cancer. Participating in a stress reduction program may help improve quality of life in patients with gynecologic or breast cancer.
Primary Outcome
Quality of life as assessed by Short Form (SF)-36
Interventions
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
- PROCEDURE psychosocial assessment and care
- BEHAVIORAL behavioral intervention
- OTHER cognitive intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-01 |
| Phase | NA |
What the finished NCT01764789 record still lists
NCT01764789 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 5 interventions - of which questionnaire administration is the first listed.
NCT01764789 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01764789 about?
NCT01764789 is a clinical study titled "Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer". This pilot clinical trial studies stress reduction in improving quality of life in patients with recurrent gynecologic or breast cancer. Participating in a stress reduction program may help improve quality of life in patients with gynecologic or breast cancer.
What is the current status of trial NCT01764789?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2010-10. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01764789?
The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), psychosocial assessment and care (PROCEDURE), behavioral intervention (BEHAVIORAL), cognitive intervention (OTHER).
Who is sponsoring clinical trial NCT01764789?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01764789's enrollment target sits among peer trials
39 1536th of 2000 higher than 463 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia